Page:United States Statutes at Large Volume 98 Part 2.djvu/1179

 PUBLIC LAW 98-507—OCT. 19, 1984

98 STAT. 2339

Public Law 98-507 98th Congress An Act To provide for the establishment of the Task Force on Organ Transplantation and the Organ Procurement and Transplantation Network, to authorize financial assistance for organ procurement organizations, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled. That this Act may be cited as the "National Organ Transplant Act". TITLE I—TASK FORCE ON ORGAN PROCUREMENT AND TRANSPLANTATION

Oct. 19, 1984 [S. 2048]

National Organ Transplant Act. 42 USC 201 note. Health.

ESTABLISHMENT AND DUTIES OF TASK FORCE

SEC. 101. (a) Not later than ninety days after the date of the 42 USC 273 note. enactment of this Act, the Secretary of Health and Human Services (hereinafter in this title referred to as the "Secretary") shall establish a Task Force on Organ Transplantation (hereinafter in this title referred to as the "Task Force"). (b)(1) The Task Force shall— (A) conduct comprehensive examinations of the medical, legal, ethical, economic, and social issues presented by human organ procurement and transplantation, (B) prepare the assessment described in paragraph (2) and the report described in paragraph (3), and (C) advise the Secretary with respect to the development of regulations for grants under section 371 of the Public Health Service Act. Post, p. 2342. (2) The Task Force shall make an assessment of immunosuppressive medications used to prevent organ rejection in transplant patients, including— (A) an analysis of the safety, effectiveness, and costs (including cost-savings from improved success rates of transplantation) of different modalities of treatment; (B) an analysis of the extent of insurance reimbursement for long-term immunosuppressive drug therapy for organ transplant patients by private insurers and the public sector; (C) an identification of problems that patients encounter in obtaining immunosuppressive medications; and (D) an analysis of the comparative advantages of grants, coverage under existing Federal programs, or other means to assure that individuals who need such medications can obtain them. .-;\j ^::(3) The Task Force shall prepare a report which shall include— Report. (A) an assessment of public and private efforts to procure human organs for transplantation and an identification of factors that diminish the number of organs available for transplantation; (B) an assessment of problems in coordinating the procurement of viable human organs including skin and bone;

�